Invivo Therapeutics News Headlines (NASDAQ:NVIV)

$7.12

-0.04 (-0.56 %)

(As of 02/16/2020 04:00 PM ET)

Add

Today's Range

$6.73

Now: $7.12▼

$7.80

50-Day Range

$0.18

MA: $0.69▼

$8.10

52-Week Range

$3.69

Now: $7.12▼

$52.14

Volume159,270 shs

Average VolumeN/A

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Invivo Therapeutics (NASDAQ NVIV) News Headlines

Source:

Date	Headline
	InVivo Therapeutics Holdings Corp www.bloomberg.com - February 16 at 12:58 PM
	2019 Update of InVivo Therapeutics Corp - Product Pipeline Analysis - ResearchAndMarkets.com www.businesswire.com - February 13 at 2:12 PM
	Contrasting Delcath Systems (OTCMKTS:DCTH) and Invivo Therapeutics (OTCMKTS:NVIV) www.americanbankingnews.com - February 6 at 6:45 PM
	Invivo Therapeutics Stock Set to Reverse Split on Wednesday, February 12th (NASDAQ:NVIV) www.americanbankingnews.com - February 4 at 11:02 AM
	InVivo to reverse split shares 1:30 seekingalpha.com - February 3 at 5:57 PM
	InVivo Therapeutics Announces Reverse Stock Split finance.yahoo.com - February 3 at 5:57 PM
	InVivo Therapeutics Announces Closing of Public Offering of Common Stock finance.yahoo.com - November 22 at 6:25 PM
	InVivo Therapeutics Announces Pricing of Public Offering of Common Stock finance.yahoo.com - November 21 at 12:07 PM
	InVivo Therapeutics Announces Proposed Public Offering of Common Stock finance.yahoo.com - November 18 at 12:47 PM
	InVivo Therapeutics Announces Appointment of Robert Rosenthal to Board of Directors finance.yahoo.com - November 12 at 9:43 AM
	Biotech CEO found guilty of defrauding investors finance.yahoo.com - October 29 at 1:52 PM
	InVivo Therapeutics Announces Publication of CONTEMPO Registry Study Data in Peer-Reviewed Journal Spinal Cord finance.yahoo.com - July 16 at 8:48 AM
	InVivo postpones shareholder meeting seekingalpha.com - July 12 at 8:30 AM
	InVivo Therapeutics Announces Postponement of Annual Meeting finance.yahoo.com - July 12 at 8:30 AM
	InVivo Therapeutics Announces Adjournment of Annual Meeting finance.yahoo.com - June 14 at 11:08 AM
	Five things you need to know today, and one small step for the media www.bizjournals.com - May 30 at 8:34 AM
	Enrollment underway in SCI study of InVivo's Neuro-Spinal Scaffold seekingalpha.com - May 29 at 6:53 PM
	Bob Langer-founded device-maker InVivo starts new trial after patient deaths finance.yahoo.com - May 29 at 6:53 PM
	InVivo Therapeutics Announces Enrollment of First Two Patients into the INSPIRE 2.0 Study for the Treatment of Acute Spinal Cord Injury finance.yahoo.com - May 29 at 8:29 AM
	InVivo up 2% premarket on new Neuro-Spinal Scaffold data seekingalpha.com - April 17 at 7:22 PM
	InVivo Therapeutics Announces Presentation of Twelve-Month Results from the INSPIRE Study of the Investigational Neuro-Spinal Scaffold™ in Acute Thoracic Complete Spinal Cord Injury finance.yahoo.com - April 17 at 7:22 PM
	InVivo Therapeutics Reports 2018 Year-end Financial Results and Provides Business Update www.marketwatch.com - April 1 at 8:34 AM
	Form 424B3 INVIVO THERAPEUTICS HOLD - StreetInsider.com www.streetinsider.com - January 16 at 5:50 PM
	InVivo Therapeutics appoints new finance chief seekingalpha.com - January 14 at 10:18 AM
	InVivo Therapeutics Announces Appointment of Richard Christopher as Chief Financial Officer and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) finance.yahoo.com - January 14 at 10:18 AM